OssDsign: Spine-tingling acceleration – SEB


We estimate Q2 sales of SEK 23m for the quarter, where we expect Catalyst to continue to develop strongly in the US. We expect y/y growth of 86%, mostly driven by the US where we estimate sales growth of 122%. We make minor adjustments to our estimates, raising expectations in the US, which explains most of our estimate changes. We reiterate our DCF-based mid-point value of SEK 11 per share.


SEB Research

This research has been commissioned by the company. Only for professional investors resident in EEA member states. Reports may not be distributed to the US or other jurisdictions where to do so would be unlawful. Please see the disclaimer tab for any details of investment banking services recently provided by SEB that could be considered relevant to the subject matter of this research.